Fly News Breaks for February 26, 2015
PCYC
Feb 26, 2015 | 09:03 EDT
Baird raised its price target on Pharmacyclics to $240 from $200 on the belief the company could get bought out at a premium to its current price following reports that the company has put itself up for sale. Baird reiterated its Outperform rating on Pharmacyclics shares.
News For PCYC From the Last 2 Days
There are no results for your query PCYC